What Is GHRP2 Same as GHRP-2 Acetate? (Peptide Explained)
A research team orders both 'GHRP2' and 'GHRP-2 Acetate' under the assumption they're procuring two distinct growth hormone secretagogues—only to discover after reconciliation that they've purchased the same peptide twice under two naming conventions. This confusion stems from inconsistent pharmaceutical nomenclature: GHRP2 and GHRP-2 Acetate refer to the exact same hexapeptide sequence, differing only in whether the acetate counterion is explicitly denoted in the product name. The acetate salt is present in both—it's a structural requirement for peptide stability in lyophilized form, not an optional variant.
Our team has guided hundreds of researchers through peptide procurement across institutions. The naming discrepancy between GHRP2 and GHRP-2 Acetate creates more protocol errors than any storage or reconstitution mistake—misidentifying these as distinct compounds leads to redundant ordering, incorrect dosing calculations, and flawed study designs that inadvertently double experimental variables.
What is GHRP2 same as GHRP-2 Acetate?
GHRP2 and GHRP-2 Acetate are identical peptides—the same growth hormone-releasing hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2) with acetate as the counterion salt. The naming difference reflects whether manufacturers choose to explicitly denote the acetate salt in product labeling. Both formulations contain the acetate moiety, have identical molecular weights (817.9 g/mol as the acetate salt), and stimulate growth hormone release through the same ghrelin receptor (GHS-R1a) mechanism.
The confusion isn't academic. GHRP2 and GHRP-2 Acetate share the same CAS number (158861-67-7), the same amino acid sequence, and the same pharmacological profile—any research protocol using one can substitute the other without modifying dosing, reconstitution, or expected outcomes. The acetate component is a counterion required to stabilize the peptide in solid form during lyophilization and storage; removing it would leave an unstable free base that degrades rapidly under ambient conditions. Manufacturers who label the product 'GHRP2' and those who label it 'GHRP-2 Acetate' are selling the exact same molecule—the difference is purely semantic, not chemical. This article covers why the naming split exists, how acetate functions as a stabilizing counterion, what happens when researchers misidentify these as separate compounds, and the exact reconstitution and storage protocols that apply to both.
The Chemical Identity: Why GHRP2 and GHRP-2 Acetate Are the Same Molecule
GHRP2 (Growth Hormone-Releasing Peptide 2) is a synthetic hexapeptide with the sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2. The peptide exists as a positively charged molecule due to the lysine residue at position 6, which carries a protonated amino group under physiological pH. Free peptides with charged residues are hygroscopic, unstable, and prone to aggregation—making them unsuitable for long-term storage or shipping. The acetate salt form solves this by pairing the peptide with acetate anions (CH3COO−), neutralizing the charge and allowing the compound to be lyophilized into a stable white powder.
The molecular weight of GHRP2 as the acetate salt is 817.9 g/mol—this includes the peptide backbone plus the acetate counterion. When researchers refer to 'GHRP2' without specifying the salt, they are still working with the acetate form; there is no commercial free-base version available because it would degrade within hours of exposure to moisture. Publications that cite 'GHRP-2' and those that cite 'GHRP-2 Acetate' are referencing the same compound in the same form—the acetate is implicit even when unstated. The CAS registry number 158861-67-7 applies universally, confirming that no structural distinction exists between the two names.
From a procurement standpoint, ordering both GHRP2 and GHRP-2 Acetate means purchasing duplicate inventory. Our experience working with peptide suppliers shows that naming conventions vary by manufacturer region and regulatory tradition—European suppliers often use the full 'acetate' suffix, while suppliers in other regions omit it. Neither approach changes the product composition. Researchers comparing product specifications should check the CAS number and molecular weight rather than relying on the product name alone.
Mechanism of Action: How GHRP2 (and GHRP-2 Acetate) Stimulates Growth Hormone Release
GHRP2 functions as a ghrelin mimetic, binding to the growth hormone secretagogue receptor type 1a (GHS-R1a) located on somatotroph cells in the anterior pituitary. This receptor activation triggers intracellular calcium release via the Gq protein-coupled pathway, which depolarizes the cell membrane and stimulates exocytosis of growth hormone-containing vesicles. The result is a rapid, dose-dependent increase in circulating GH levels—peak plasma GH concentrations occur 15–30 minutes post-administration and return to baseline within 90–120 minutes.
Unlike endogenous ghrelin, which also stimulates appetite through hypothalamic circuits, GHRP2 has significantly weaker orexigenic effects due to its structural modifications at positions 1, 2, and 5 (the D-amino acid substitutions). These modifications were engineered specifically to enhance GH release selectivity while minimizing appetite stimulation. The D-2-Nal residue at position 2—a non-natural aromatic amino acid—is particularly critical for receptor binding affinity, improving potency approximately 10-fold compared to first-generation peptides like GHRP-6.
The acetate salt does not participate in the receptor-binding mechanism. Once reconstituted and administered, the peptide dissociates from the acetate counterion in solution, leaving the active hexapeptide free to bind GHS-R1a. Whether the product was labeled GHRP2 or GHRP-2 Acetate has zero impact on pharmacodynamics—the amino acid sequence determines receptor interaction, and both names describe the same sequence.
GHRP2 Same as GHRP-2 Acetate: Reconstitution and Storage Protocols
Both GHRP2 and GHRP-2 Acetate are supplied as lyophilized white powder and require reconstitution with bacteriostatic water (0.9% benzyl alcohol) before use. The standard reconstitution protocol is 2 mL bacteriostatic water per 5 mg peptide vial, yielding a 2.5 mg/mL solution. Inject the water slowly down the side of the vial to avoid foaming—direct injection onto the lyophilized cake can denature the peptide through mechanical shear stress. Allow the vial to sit undisturbed for 60–90 seconds; gentle swirling is acceptable if powder remains after two minutes, but never shake the vial.
Unreconstituted lyophilized GHRP2 (or GHRP-2 Acetate) should be stored at −20°C in a sealed container with desiccant to prevent moisture absorption. At this temperature, the peptide remains stable for 24–36 months from manufacture date. Once reconstituted, the peptide must be refrigerated at 2–8°C and used within 28 days—the benzyl alcohol in bacteriostatic water provides antimicrobial protection, but does not prevent oxidation or aggregation of the peptide itself over extended periods. Temperature excursions above 8°C—even briefly—accelerate degradation exponentially; a vial left at room temperature (22°C) for 12 hours loses approximately 15–20% potency, and the loss is irreversible.
The acetate salt does not alter storage requirements. GHRP2 labeled without the 'acetate' suffix follows identical temperature protocols because it contains the same counterion. Researchers switching between suppliers who use different naming conventions can apply the same storage and handling SOPs without modification. Real Peptides provides comprehensive storage guidelines with every order, ensuring researchers understand that GHRP2 and GHRP-2 Acetate are managed identically in the lab.
GHRP2 Same as GHRP-2 Acetate: Dosing, Purity Standards, and Research Applications Comparison
Molecular Weight
817.9 g/mol (as acetate salt)
Identical—naming does not change molecular structure
CAS Number
158861-67-7
Same registry number confirms chemical equivalence
Amino Acid Sequence
D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
No sequence variation—both are the same hexapeptide
Purity Standard
≥98% by HPLC
Industry standard applies uniformly regardless of label
Typical Research Dose Range
100–300 mcg per administration
Dosing protocols are interchangeable between products
Reconstitution Protocol
2 mL bacteriostatic water per 5 mg vial
Same preparation method—no formulation difference
Storage (Lyophilized)
−20°C, sealed with desiccant
Temperature and handling requirements are identical
Storage (Reconstituted)
2–8°C, use within 28 days
Stability timeline is the same for both naming conventions
Bottom Line
GHRP2 and GHRP-2 Acetate are the same peptide with identical specifications—ordering both results in duplicate inventory with no experimental benefit
Key Takeaways
GHRP2 and GHRP-2 Acetate are chemically identical peptides with the same molecular weight (817.9 g/mol), CAS number (158861-67-7), and hexapeptide sequence (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2).
The acetate salt is present in both formulations—it stabilizes the peptide during lyophilization and storage, and manufacturers differ only in whether they explicitly denote it in product labeling.
Both GHRP2 and GHRP-2 Acetate bind the GHS-R1a receptor with identical affinity and stimulate growth hormone release through the same Gq-coupled calcium signaling pathway.
Reconstitution, storage, and dosing protocols are interchangeable—2 mL bacteriostatic water per 5 mg vial, storage at −20°C before reconstitution and 2–8°C after, with a 28-day post-reconstitution shelf life.
Ordering both GHRP2 and GHRP-2 Acetate under the assumption they are distinct compounds results in duplicate procurement and introduces unnecessary inventory tracking complexity.
Research publications using one naming convention versus the other are referencing the same molecule—CAS number verification confirms equivalence across all literature sources.
What If: GHRP2 Same as GHRP-2 Acetate Scenarios
What If a Researcher Accidentally Orders Both GHRP2 and GHRP-2 Acetate Thinking They Are Different Peptides?
This happens frequently in labs with decentralized procurement. Verify equivalence immediately by comparing CAS numbers (both should be 158861-67-7) and molecular weights (both 817.9 g/mol). If confirmed identical, consolidate inventory under one label to prevent protocol confusion. Do not attempt to use both in parallel experimental arms—they are the same compound and will produce identical results, invalidating any comparative analysis. Update your lab's internal nomenclature guide to specify that GHRP2 and GHRP-2 Acetate refer to the same peptide, and cross-reference future orders against CAS numbers rather than product names alone.
What If a Study Protocol Specifies 'GHRP-2 Acetate' but the Supplier Only Sells 'GHRP2'?
Proceed with the GHRP2 product without modification. The protocol author's use of 'GHRP-2 Acetate' reflects their supplier's labeling preference, not a distinct chemical requirement. Confirm that the GHRP2 product lists the acetate salt in its certificate of analysis (all commercial GHRP2 is the acetate form) and that the CAS number matches 158861-67-7. No dosing adjustment is needed—100 mcg of GHRP2 is 100 mcg of GHRP-2 Acetate. Document the equivalence in your study records to maintain protocol fidelity during audit or publication.
What If Reconstituted GHRP2 and GHRP-2 Acetate Appear to Have Different Solubility or Clarity?
Visual differences post-reconstitution indicate batch-to-batch purity variation or improper storage—not a chemical distinction between GHRP2 and GHRP-2 Acetate. Both should dissolve completely in bacteriostatic water within 90 seconds, yielding a clear, colorless solution. Cloudiness, particulates, or incomplete dissolution suggest peptide aggregation caused by temperature excursions during shipping or storage (exposure above 8°C for reconstituted vials or above −10°C for lyophilized powder). Discard any vial showing visual abnormalities and contact the supplier for a replacement with full cold-chain documentation. Do not attempt to salvage partially degraded peptide—aggregated peptides have unpredictable receptor binding kinetics.
The Direct Truth About GHRP2 Same as GHRP-2 Acetate
Here's the honest answer: GHRP2 and GHRP-2 Acetate are not two versions of a peptide—they are one peptide with two names. The acetate is always present; it's a required counterion for peptide stability, not an optional formulation variant. Labs that order both thinking they're procuring distinct compounds waste budget and introduce inventory confusion that can cascade into protocol errors. The naming inconsistency persists because peptide suppliers follow different regional labeling conventions—some explicitly state the salt, others omit it—but the chemical identity never changes. Verify equivalence using CAS numbers, not product names, and eliminate duplicate orders by cross-referencing molecular structure rather than trusting label text.
GHRP2 and GHRP-2 Acetate function identically in every measurable parameter: receptor binding affinity, GH release kinetics, reconstitution behavior, and storage stability. If a study requires one and your supplier provides the other, no substitution is occurring—you're receiving the exact same molecule. The底 line: consolidate your procurement records, update internal nomenclature guides to reflect chemical equivalence, and stop treating these as separate line items. The only difference is the label—and labels don't determine molecular behavior.
Researchers looking to source high-purity GHRP2 for cutting-edge biological studies can explore premium research peptides crafted through small-batch synthesis with exact amino-acid sequencing. Whether labeled GHRP2 or GHRP-2 Acetate, precision begins with understanding what you're actually working with—not just what the packaging says.
The peptide research landscape demands precision. GHRP2 and GHRP-2 Acetate aren't competitors—they're the same tool under two names. Understanding that prevents costly mistakes, simplifies procurement, and keeps your protocols scientifically sound. If the naming bothers you, change your internal labeling system. The molecule doesn't care what you call it—it only cares how you store it, reconstitute it, and apply it to your research questions.
Frequently Asked Questions
GHRP2 and GHRP-2 Acetate are the same peptide—the identical hexapeptide sequence (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2) paired with acetate as the counterion salt. The naming difference reflects whether manufacturers explicitly state the acetate component in product labeling. Both share the same CAS number (158861-67-7) and molecular weight (817.9 g/mol), confirming they are chemically identical. The acetate salt is present in both—it’s a structural requirement for lyophilized stability, not an optional variant.
Yes—GHRP2 and GHRP-2 Acetate are completely interchangeable because they are the same compound. Dosing, reconstitution, storage, and expected pharmacological outcomes are identical across both naming conventions. A protocol specifying ‘GHRP-2 Acetate’ can use a product labeled ‘GHRP2’ without any modification to dose calculations or experimental design. Verify equivalence by confirming the CAS number (158861-67-7) matches between products.
The naming split reflects regional labeling traditions and supplier preference—not a chemical difference. Some manufacturers explicitly denote the acetate counterion (GHRP-2 Acetate) following European pharmaceutical nomenclature standards, while others use the abbreviated form (GHRP2) common in other markets. Both approaches describe the same molecule in the same salt form. The acetate is implicit even when unstated because no commercial free-base version exists—the peptide would degrade without it.
No—the acetate counterion stabilizes the peptide during lyophilization and storage but dissociates upon reconstitution and does not participate in receptor binding. Once dissolved in bacteriostatic water, the peptide separates from the acetate, leaving the active hexapeptide free to bind the GHS-R1a receptor. The mechanism of action, GH release kinetics, and pharmacological profile are determined entirely by the amino acid sequence, not the counterion salt.
You will have duplicate inventory of the same peptide under two names. Verify equivalence by comparing CAS numbers (both should be 158861-67-7) and consolidate the stock under one label to prevent protocol confusion. Do not use both in parallel experimental arms—they are chemically identical and will produce the same results, invalidating any comparative analysis. Update procurement records to prevent future duplicate orders.
Store unreconstituted lyophilized GHRP2 at −20°C in a sealed container with desiccant—the peptide remains stable for 24–36 months under these conditions. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28 days. Temperature excursions above 8°C (even briefly) cause irreversible degradation—a vial left at room temperature for 12 hours loses 15–20% potency. Both GHRP2 and GHRP-2 Acetate follow identical storage protocols.
Add 2 mL bacteriostatic water (0.9% benzyl alcohol) per 5 mg peptide vial, injecting slowly down the side of the vial to avoid foaming. Allow the vial to sit undisturbed for 60–90 seconds—gentle swirling is acceptable if powder remains, but never shake. This yields a 2.5 mg/mL solution. The protocol is identical for both GHRP2 and GHRP-2 Acetate because they are the same peptide in the same salt form.
GHRP2 has approximately 10-fold higher GHS-R1a receptor binding affinity compared to GHRP-6 due to the D-2-Nal residue at position 2—a non-natural aromatic amino acid that enhances receptor interaction. GHRP2 also produces significantly weaker appetite stimulation than GHRP-6 because its structural modifications reduce activation of hypothalamic orexigenic circuits. Both peptides stimulate GH release through the same Gq-coupled calcium pathway, but GHRP2 achieves the effect at lower doses with fewer off-target effects.
Yes—all commercially available GHRP2 is supplied as the acetate salt because the free-base form is too unstable for storage or shipping. If a product is labeled simply ‘GHRP2’ without mentioning acetate, the acetate is still present—it’s an implicit component required for lyophilization. Check the certificate of analysis for molecular weight (817.9 g/mol confirms the acetate salt) or verify the CAS number (158861-67-7). The absence of ‘acetate’ in the product name does not indicate a different formulation.
Research-grade GHRP2 and GHRP-2 Acetate should meet ≥98% purity by HPLC analysis, verified by the supplier’s certificate of analysis. Purity below 98% indicates contamination with truncated sequences, aggregates, or residual synthesis byproducts—all of which compromise experimental reproducibility. The purity standard applies universally regardless of whether the product is labeled GHRP2 or GHRP-2 Acetate because they are the same peptide subject to the same quality control benchmarks.